Multi-Analyte, Swab-based Automated Wound Monitor with AI

Amay Bandodkar; Gurudatt Nanjanagudu Ganesh; Imon Banerjee; Lalith Appari; Madhu Babu Sikha

REVIEW 3 major objections 5 minor 11 references

Multi-Analyte, Swab-based Automated Wound Monitor with AI

T0 review · 3 major / 5 minor · reviewed 2026-08-07 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read This paper claims that photographing a lactate-sensitive swab before and after wound exposure, then comparing per-channel color intensity with computer vision, automatically determines wound severity for diabetic foot ulcers.

desk verdict A proof-of-concept with a re-implementable vision pipeline whose wound-severity claim rests on two image pairs and no assay validation. read the letter →

arxiv 2506.03188 v1 pith:MR6SDRRN submitted 2025-05-30 eess.IV cs.AIcs.CVcs.HC

Madhu Babu Sikha , Lalith Appari , Gurudatt Nanjanagudu Ganesh , Amay Bandodkar , Imon Banerjee This is my paper

classification eess.IVcs.AIcs.CVcs.HC

keywords diabeticfootulcerscolorimetricsensorslactatesensingwoundmonitoringcomputervisioniOSapplicationpoint-of-carediagnostics3D-printedassays

verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Wound monitoring for diabetic foot ulcers is this paper's target: roughly 70% of DFUs go unhealed, and existing clinical assessment is subjective and lacks quantitative biochemical data. The paper tries to establish that a low-cost, multi-analyte 3D-printed assay mounted on swabs, read through a custom iOS app, can automatically determine wound severity by comparing a base image of the unexposed assay with an image taken after the swab contacts the wound. The measured quantity is the drop in mean pixel intensity across color channels, interpreted as a colorimetric response to lactate in wound exudate. If the causal link between that intensity drop and lactate holds, the app would give clinicians a real-time, point-of-care severity readout and a way to track healing over time.

What carries the argument

The central object is the lactate-sensing swab: a 2 mm-diameter peroxidase swab punch coated with 120 mg/mL lactate oxidase, stabilized by a chitosan and glutaraldehyde cage so the enzyme does not leach, and mounted on a 3D-printed post alongside other assay swabs. The carrying mechanism is the image pipeline: after HSV color-space conversion, a yellow mask selects the assay regions, morphological opening and closing clean the mask, Difference-of-Gaussians blob detection finds the four assay spots, contour filtering keeps the four largest regions, and equation (11) computes the per-channel intensity difference. That number is the paper's quantitative handle on wound severity; the argument is that a larger blue/green darkening corresponds to a stronger lactate response and therefore a more severe or more biochemically active wound.

What would settle it

Use the same protocol to photograph a swab post before and after wetting it with lactate-free buffer or saline; if the blue and green intensity drops match the 30 mM lactate images, the app cannot tell a wet swab from a reactive one. Then run a dilution series from 0 mM to clinically relevant lactate concentrations; if the intensity difference is not monotonic, the app is not measuring severity.

Watch

Extended reading notes

Core claim

On the paper's own terms, the discovery is that an enzymatic colorimetric assay can be attached to a standard swab and read by a phone camera: the app finds the four assay spots in both the pre-exposure and post-exposure images, isolates each one with HSV thresholding, morphological filtering, Difference-of-Gaussians blob detection, and contour filtering, and computes per-channel mean intensity differences $\Delta I_{i,c}$. The paper reports that the blue and green channels darken after exposure to wound exudate with 30 mM lactate, which it reads as evidence that the assay responds to the target analyte. From this it concludes that the integrated sensor-and-app system can identify non-healing DFUs early, monitor wound conditions in real time, and track healing progress, replacing subjective inspection with an automated quantitative metric.

Load-bearing premise

The entire readout depends on the assumption that the darkening measured by the app is caused specifically and quantitatively by lactate in the wound exudate, not by wetting, pH, ambient light, or other interferents.

Editorial extensions

If this is right

Clinicians could get a numeric severity readout at the point of care from a standard smartphone, without subjective visual inspection of the wound itself.
Early identification of non-healing DFUs becomes feasible in homes and clinics, potentially catching wounds before they become chronic and amputation-prone.
Because each assay spot is analyzed independently, the same app can score multiple biomarkers from one photograph as more analyte-specific swabs are added.
Repeated measurements over visits would turn the app into a longitudinal healing tracker, letting care teams compare severity metrics rather than rely on memory or photos.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

Because the paper demonstrates only a single lactate concentration (30 mM), the obvious next step is a dose-response study; if the blue/green intensity drop is not monotonic with lactate concentration, the severity readout would need recalibration.
The paper frames the post as multi-analyte but proves only the lactate swab; swapping in other enzymes would make the same before/after imaging pipeline a general multi-biomarker wound dashboard.
The first decisive control experiment, which the paper does not report, is a wet-only swab: a buffer- or saline-wetted post that darkens like the lactate case would show the signal is a wetness artifact rather than a chemistry measurement.

Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Desk Editor's Note

read the letter

The paper is a proof-of-concept engineering report, not a validated diagnostic. What is genuinely new is the integration: a 3D-printed multi-swab lactate post, an iOS app with controlled capture, and a base-versus-exposed intensity difference. Relative to the cited smart-dressing and wound-imaging literature, that combination is new. What it does well: the image-processing derivation in Section II.B is standard and mostly correctly specified, with explicit parameter values, and the workflow is re-implementable from the text. The 2mm assay diameter fix is a sensible engineering response, and the 'Challenges' section is candid about autofocus issues.

Soft spots: The load-bearing link is the claim that the measured intensity difference is specifically and quantitatively caused by lactate and thus indicates wound severity. That link is asserted, not shown. The results are two example image pairs, both at a single 30 mM lactate concentration, with no negative control (e.g., a buffer-wetted swab), no calibration curve, no replicates, no error bars. A wet-only swab could darken the same way, and ambient lighting changes between captures could confound the difference. Without a dose-response curve, the numeric ΔI values cannot be interpreted as a severity metric. This is a gap in evidence, not a flaw in the vision pipeline itself. The morphological labeling error in Eq. (3) is minor and does not affect the argument.

The HSV bounds, DoG sigmas, and blob threshold were tuned on the same images that are shown as results; that is a mild circularity, but not the central problem, since no outcome is fitted.

Bottom line: the clinical claim in the abstract and introduction outruns the data. A version that claimed only automated extraction of assay color change would be a credible prototype report. As is, the paper is a useful existence proof for system integration, but not a validation of wound monitoring. I'd bring it to a reading group to discuss overclaiming in sensor papers, not for the methods. I would not cite it in my own work because there is no data or code shipped.

For peer review: I'd send it out only if the editor is willing to require the authors to add a negative control and a lactate dose-response series with replicates. Without that, the central claim should be rejected.

Referee Report

3 major / 5 minor

Summary. The manuscript describes a low-cost 3D-printed multi-analyte swab assay for lactate detection in wound exudate, together with an iOS app that captures before/after images of the assay and uses a deterministic computer-vision pipeline (HSV thresholding, morphological operations, DoG blob detection, contour cropping, and per-channel mean intensity subtraction) to compute intensity differences ΔI between base and exposed images. The authors claim that these intensity differences allow automated determination of wound severity in diabetic foot ulcers, with the app intended as a point-of-care monitoring tool. Section II.B specifies the pipeline in Eqs. (1)–(11); Section III presents two example image pairs, both at a single 30 mM lactate concentration, and reports qualitative darkening of the blue/green channels. The paper concludes that the system can quantify wound severity metrics in real time.

Significance. If substantiated, the concept of a smartphone-readable, swab-embedded colorimetric assay for wound biomarkers would address a real clinical need for objective, point-of-care monitoring of diabetic foot ulcers. The manuscript's image-processing pipeline is standard, clearly described, and reproducible from the equations and parameter values given. However, the central claim—that the measured ΔI is specifically and quantitatively related to lactate concentration and thus wound severity—is not supported by the evidence presented. The work is a technical workflow demonstration rather than a validated diagnostic; its significance is therefore conditional on substantial additional experimental validation.

major comments (3)

[Section III, Figs. 4 and 5] The central claim that ΔI_{i,c} from Eq. (11) determines wound severity is unsupported by the results. The paper shows only two example image pairs, both at a single 30 mM lactate concentration, with no negative control (e.g., a swab wetted with buffer or saline without lactate, or a dry swab), no calibration curve relating ΔI to lactate concentration, no replicate measurements, and no error bars. Without a wet-only control, the observed darkening in the blue and green channels could equally be caused by wetting, pH changes, or ambient lighting variations rather than by lactate. Without a dose-response curve, the numerical ΔI values cannot be interpreted as a severity metric. This is load-bearing because the abstract and conclusion explicitly claim that the app 'automatically determine[s] the severity of the wound.'
[Section II.A, Fig. 1] The specificity and quantitativeness of the colorimetric lactate assay are asserted rather than demonstrated. The paper does not provide any characterization of the lactate oxidase/peroxidase reaction such as absorbance spectra, a calibration curve, limits of detection, or interference studies against pH, temperature, or common wound-exudate components (e.g., urate, ascorbate, other metabolites). Consequently, the fundamental link between the measured ΔI and lactate concentration is missing. Even a perfectly executed image-processing pipeline cannot establish the clinical claim if the underlying assay is not shown to respond specifically and quantitatively to the target analyte.
[Title, Abstract, Section II.B] The title and abstract describe the system as using 'AI' and as able to 'automatically determine the severity of the wound,' but the pipeline in Section II.B is a deterministic sequence of standard image-processing operations (HSV thresholding, morphological filtering, DoG blob detection, contour selection, and mean intensity subtraction) with no learned or statistical model. The parameters (HSV bounds, structuring element, DoG sigmas, blob threshold) are fixed and appear to be tuned on the same two image pairs, with no validation set. The language overstates the scope of the technical contribution and risks misleading readers about the system's capabilities.

minor comments (5)

[Section II.B, Eq. (3)] Equation (3) contains a terminology error: the text describes 'morphological opening (dilation) and closing (erosion),' but opening is erosion followed by dilation, and closing is dilation followed by erosion. The equations themselves implement opening and closing correctly, so this is purely a labeling issue, but it should be corrected for clarity.
[Section II.B, Eq. (2)] Equation (2) defines the yellow mask using the condition L_yellow ≤ I_HSV(x,y,c') ≤ U_yellow for all channels c'. Since the HSV bounds are given as [20,150,150] and [30,255,255], it should be clarified whether the comparison is elementwise across H, S, and V and how the '∀c'' condition is applied (e.g., conjunction of per-channel thresholds versus a single vector inequality).
[Section III, paragraph after Fig. 4] The text states 'the decrease in mean intensity values for both the blue and green channels in the exposed image compared to the baseline indicates a darkening effect,' but the figures are not accompanied by numerical values in the text. Reporting the actual ΔI values and their standard deviations (if replicates exist) would allow readers to assess the significance of the changes.
[Section II.B, step (v)] The description says 'We considered only four contours with maximum area which are assumed to correspond to four assays,' but the assay post appears to contain four swabs. If the number of assays is fixed, this should be stated; if the assay post can vary, the hard-coded number four may limit generalizability.
[General] The reference list includes standard image-processing texts but lacks citations for the lactate oxidase/peroxidase colorimetric reaction and for the clinical interpretations of lactate in wound exudate. Adding such references would strengthen the biochemical and clinical context.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: the intensity-difference computation is a direct measurement, not a fitted prediction.

full rationale

The paper's derivation chain computes the assay intensity change by direct image arithmetic: Eq. (11) defines ΔI_{i,c} as the difference between measured mean channel intensities of the exposed and base images. No parameter in that chain is fit to the outcome it is used to predict; the outcome itself is the measured intensity difference. The yellow-mask HSV bounds, structuring-element size, DoG sigmas, and blob threshold reported in Section III are fixed segmentation parameters, not learned weights, and the paper does not claim a separate validation set or a statistical prediction from fitted inputs. The most serious weakness, that the ΔI values are never shown to be specifically and quantitatively caused by lactate via negative controls or a dose-response curve, is a threat to external validity of the clinical claim rather than a circular reduction of the derivation to its inputs. There is no load-bearing self-citation and no uniqueness theorem imported from the authors' prior work. Accordingly, no circular step meeting the required evidentiary standard is present.

Assumptions & free parameters 6 free parameters · 5 assumptions · 0 invented entities

The central claim rests on unvalidated domain assumptions rather than on fitted models. There are no free parameters fit to a clinical outcome, so circularity burden is low; the load-bearing risk is that the measured intensity difference is treated as lactate-specific and severity-linked without calibration or controls. The hand-chosen HSV thresholds, morphological kernel, DoG sigmas, and blob threshold are pipeline constants tuned to the displayed images, not validated on held-out data.

free parameters (6)

HSV yellow mask lower bound L_yellow = [20, 150, 150]
Hand-chosen HSV thresholds to segment the yellow assay. No robustness analysis across lighting or phone models is given (Eq. (2), Section III).
HSV yellow mask upper bound U_yellow = [30, 255, 255]
Upper bound of the same hand-tuned mask. The narrow hue band makes segmentation sensitive to white-balance shifts.
Morphological structuring element K = 5x5 rectangular
Chosen to denoise the binary mask. Effect on the small 2 mm assay ROIs is not analyzed.
DoG standard deviations sigma_1, sigma_2 = 1.5 and 3.0 pixels
Used to enhance blob-like assay structures. Not justified relative to assay pixel size at typical capture distances (Section III).
Blob detection threshold T_blob = 100
Threshold on the DoG response to select assay blobs. Sensitivity is unreported (Eq. (7), Section III).
Number of assay contours = 4 (largest contours)
Assumes the four largest detected blobs are the four assays. This fails if the background contains yellow objects or an assay is missed (Section II.B, step v).

assumptions (5)

domain assumption HSV thresholding with the chosen bounds separates assay pixels from background across devices and lighting.
Eq. (2) assumes lighting robustness, but no multi-device or multi-lighting validation is shown.
domain assumption The four largest detected blobs are the four assays in both base and exposed images.
Section II.B step (v); fails if the background contains yellow objects or if an assay is missed.
domain assumption Mean channel intensity within the ROI is a monotonic quantitative proxy for analyte concentration.
Eqs. (10)-(11); no calibration curve links the intensity difference to lactate concentration.
domain assumption The observed darkening is caused by the lactate-enzyme reaction, not by wetting, pH, or temperature.
Section II.A and Fig. 1; no negative control or interference study is presented.
domain assumption Base and exposed images are photometrically comparable after in-app capture controls.
Section II.B; no color-calibration target or exposure metering validation, so a lighting change between photos can masquerade as a signal.

how reviews work

0 comments

Cite this review

Pith. "Pith review of Multi-Analyte, Swab-based Automated Wound Monitor with AI." pith.science (2026). https://pith.science/paper/MR6SDRRN

@misc{pith2026250603188,
  author       = {Pith},
  title        = {Pith review of: Multi-Analyte, Swab-based Automated Wound Monitor with AI},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/MR6SDRRN}},
  note         = {Machine review of arXiv:2506.03188}
}

read the original abstract

Diabetic foot ulcers (DFUs), a class of chronic wounds, affect ~750,000 individuals every year in the US alone and identifying non-healing DFUs that develop to chronic wounds early can drastically reduce treatment costs and minimize risks of amputation. There is therefore a pressing need for diagnostic tools that can detect non-healing DFUs early. We develop a low cost, multi-analyte 3D printed assays seamlessly integrated on swabs that can identify non-healing DFUs and a Wound Sensor iOS App - an innovative mobile application developed for the controlled acquisition and automated analysis of wound sensor data. By comparing both the original base image (before exposure to the wound) and the wound-exposed image, we developed automated computer vision techniques to compare density changes between the two assay images, which allow us to automatically determine the severity of the wound. The iOS app ensures accurate data collection and presents actionable insights, despite challenges such as variations in camera configurations and ambient conditions. The proposed integrated sensor and iOS app will allow healthcare professionals to monitor wound conditions real-time, track healing progress, and assess critical parameters related to wound care.

Figures

Figures reproduced from arXiv: 2506.03188 by the authors.

**Figure 3.** shows the screenshot of our iOS app which shows the base image, exposed image and results displayed on the results page [PITH_FULL_IMAGE:figures/full_fig_p003_3.png] view at source ↗

Discussion (0). Sign in to comment.

Reference graph

Works this paper leans on

11 extracted references · 11 canonical work pages

[1]

Diabetic foot infections: a comprehensive overview,

Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, Fiori B, Caputo S, Tinelli G, Zaccardi F, Flex A, Galli M, Pontecorvi A, Sanguinetti M, “Diabetic foot infections: a comprehensive overview,” Eur Rev Med Pharmacol Sci., vol. 23(2 Suppl), pp. 26-37, Apr. 2019

work page 2019
[2]

Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers ,

McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW , “Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers ,” Diabetes Care, vol. 46, no. 1, pp. 209-221, Jan. 2023

work page 2023
[3]

Strategy for Treatment of Infected Diabetic Foot Ulcers,

Chang M, Nguyen TT, “Strategy for Treatment of Infected Diabetic Foot Ulcers,” Acc Chem Res, vol. 54, no. 5, pp. 1080-1093, Mar. 2021

work page 2021
[4]

Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers,

William J. Jeffcoate, Loretta Vileikyte, Edward J. Boyko, David G. Armstrong, Andrew J.M. Boulton , “Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers,” Diabetes Care, vol. 41, no. 4, pp. 645–652, Apr. 2018

work page 2018
[5]

The use of antimicrobial dressings in chronic wounds: NERDS and STONEES principles,

Woo KY, “The use of antimicrobial dressings in chronic wounds: NERDS and STONEES principles,” Surg Technol Int., vol. 20, pp. 73 -82, Oct. 2010

work page 2010
[6]

Diabetic Foot Ulcers: A Review,

Armstrong DG, Tan TW, Boulton AJM, Bus SA, “Diabetic Foot Ulcers: A Review,” JAMA, vol. 330, no. 1, pp. 62-75, Jul. 2023

work page 2023
[7]

‘Smart’wound dressings for advanced wound care: a review

O'Callaghan, Suzanne, Paul Galvin, Conor O'Mahony, Zena Moore, and Rosemarie Derwin, "‘Smart’wound dressings for advanced wound care: a review." Journal of wound care, vol. 29, no. 7, pp. 394-406 , Jul. 2020

work page 2020
[8]

Promoting Self-Care of Diabetic Foot Ulcers Through a Mobile Phone App: User-Centered Design and Evaluation,

Ploderer B, Brown R, Seng LSD, Lazzarini PA, van Netten JJ , “Promoting Self-Care of Diabetic Foot Ulcers Through a Mobile Phone App: User-Centered Design and Evaluation,” JMIR Diabetes, vol. 4, no. 4, Feb. 2018

work page 2018

Show all 11 references

[9]

Diabetic Foot Surveillance Using Mobile Phones and Automated Software Messaging, a Randomized Observational Trial,

Anthony CA, Femino JE, Miller AC, Polgreen LA, Rojas EO, Francis SL, Segre AM, Polgreen PM , “Diabetic Foot Surveillance Using Mobile Phones and Automated Software Messaging, a Randomized Observational Trial,” Iowa Orthop J., vol. 40, no. 1, pp. 35-42, 2020

2020
[10]

Initial Clinical Experience with a Simple, Home System for Early Detection and Monitoring of Diabetic Foot Ulcers: The Foot Selfie,

Swerdlow M, Shin L, D’Huyvetter K, Mack WJ, Armstrong DG, “Initial Clinical Experience with a Simple, Home System for Early Detection and Monitoring of Diabetic Foot Ulcers: The Foot Selfie,” Journal of Diabetes Science and Technology, vol. 17, no. 1, pp. 79-88. Oct. 2021

2021
[11]

Digital Image Processing using MATLAB

Rafael C. Gonzalez, Richard E. Woods, Steven L. Eddins, “Digital Image Processing using MATLAB”, 3rd ed. , Gatesmark publishing, Jan. 2020

2020

Pith tools

Reviewed August 7, 2026 · model on record in the stance chip above.

[1] [1]

Diabetic foot infections: a comprehensive overview,

Pitocco D, Spanu T, Di Leo M, Vitiello R, Rizzi A, Tartaglione L, Fiori B, Caputo S, Tinelli G, Zaccardi F, Flex A, Galli M, Pontecorvi A, Sanguinetti M, “Diabetic foot infections: a comprehensive overview,” Eur Rev Med Pharmacol Sci., vol. 23(2 Suppl), pp. 26-37, Apr. 2019

work page 2019

[2] [2]

Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers ,

McDermott K, Fang M, Boulton AJM, Selvin E, Hicks CW , “Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers ,” Diabetes Care, vol. 46, no. 1, pp. 209-221, Jan. 2023

work page 2023

[3] [3]

Strategy for Treatment of Infected Diabetic Foot Ulcers,

Chang M, Nguyen TT, “Strategy for Treatment of Infected Diabetic Foot Ulcers,” Acc Chem Res, vol. 54, no. 5, pp. 1080-1093, Mar. 2021

work page 2021

[4] [4]

Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers,

William J. Jeffcoate, Loretta Vileikyte, Edward J. Boyko, David G. Armstrong, Andrew J.M. Boulton , “Current Challenges and Opportunities in the Prevention and Management of Diabetic Foot Ulcers,” Diabetes Care, vol. 41, no. 4, pp. 645–652, Apr. 2018

work page 2018

[5] [5]

The use of antimicrobial dressings in chronic wounds: NERDS and STONEES principles,

Woo KY, “The use of antimicrobial dressings in chronic wounds: NERDS and STONEES principles,” Surg Technol Int., vol. 20, pp. 73 -82, Oct. 2010

work page 2010

[6] [6]

Diabetic Foot Ulcers: A Review,

Armstrong DG, Tan TW, Boulton AJM, Bus SA, “Diabetic Foot Ulcers: A Review,” JAMA, vol. 330, no. 1, pp. 62-75, Jul. 2023

work page 2023

[7] [7]

‘Smart’wound dressings for advanced wound care: a review

O'Callaghan, Suzanne, Paul Galvin, Conor O'Mahony, Zena Moore, and Rosemarie Derwin, "‘Smart’wound dressings for advanced wound care: a review." Journal of wound care, vol. 29, no. 7, pp. 394-406 , Jul. 2020

work page 2020

[8] [8]

Promoting Self-Care of Diabetic Foot Ulcers Through a Mobile Phone App: User-Centered Design and Evaluation,

Ploderer B, Brown R, Seng LSD, Lazzarini PA, van Netten JJ , “Promoting Self-Care of Diabetic Foot Ulcers Through a Mobile Phone App: User-Centered Design and Evaluation,” JMIR Diabetes, vol. 4, no. 4, Feb. 2018

work page 2018